Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD

Online download statistics by month:

Online download statistics by month: February 2022 to March 2024

	Abstract	Full	Pdf
Feb 2022	228	3	1
Mar 2022	952	5	9
Apr 2022	340	2	2
May 2022	320	2	1
Jun 2022	227	5	1
Jul 2022	195	3	1
Aug 2022	258	3	1
Sep 2022	264	4	2
Oct 2022	290	6	3
Nov 2022	404	8	4
Dec 2022	206	3	2
Jan 2023	186	0	0
Feb 2023	182	0	2
Mar 2023	182	1	0
Apr 2023	137	1	2
May 2023	150	2	1
Jun 2023	138	0	0
Jul 2023	228	2	0
Aug 2023	141	1	2
Sep 2023	142	4	2
Oct 2023	160	0	0
Nov 2023	103	1	1
Dec 2023	195	5	3
Jan 2024	422	17	11
Feb 2024	326	6	5
Mar 2024	86	4	1
Total	6462	88	57